AzTrials
AzTrials

Blood Flow Restriction ExerciseBFRTNCT06962514

Low Load With Blood Flow Restriction for Improving Strength, Balance, and Cognition in Older Adults

A study testing Blood flow restriction cuff and Exercise without BFR cuff in people with Blood Flow Restriction Exercise and Resistance Training, run by Sahmyook University at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to examine the effects of low load resistance exercise with a blood flow restriction cuff on muscle strength, balance, physical performance, depression, and cognitive function in community-dwelling older adults. Read more about this study

Who is it for?
Ages 65 years and older
What is being tested?
Blood flow restriction cuff and Exercise without BFR cuff
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteSouth Korea
Study dates
12 May 2025to 14 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Community-dwelling individuals aged 65 years and older who have not had a fall in the past year.
  • No neurological or musculoskeletal condition that would interfere with exercise performance.
  • Clear consciousness and able to communicate effectively.
  • Capable of reading and writing.
  • Able to understand the research explanation and provide informed consent.

Who cannot join

  • Orthopedic, neurological, or vascular conditions that may affect vital signs such as dizziness, blood pressure instability, or fall risk during assessment.
  • Any history of musculoskeletal surgery within the past 6 months.
  • Physician-determined health status that contraindicates exercise participation.
  • Cognitive or literacy impairments that hinder understanding of study procedures.

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Sahmyook University, Graduate School of Physical Therapy

    Seoul, 01795

Other trials in South Korea

About this study

Official title: Effects of Low Load Resistance Exercise With a Blood Flow Restriction Cuff on Strength, Balance, Physical Performance, Depression and Cognition in Older Adults: a Randomized Controlled Study

This study aims to examine the effects of low load resistance exercise with a blood flow restriction cuff on muscle strength, balance, physical performance, depression, and cognitive function in community-dwelling older adults.

Read the detailed description

This randomized controlled trial investigates the effects of low-load resistance exercise combined with blood flow restriction (BFR) in community-dwelling older adults. A total of 26 participants aged 65 and older will be randomly assigned to either a BFR exercise group or a control group that performs the same resistance exercises without BFR.

The intervention will be conducted twice a week for 8 weeks (16 sessions total). The BFR cuffs will be applied at 50% of the participant's arterial occlusion pressure. Both groups will undergo the same exercise protocol, supervised by trained personnel. Assessments will be performed at baseline and after the intervention.

Primary outcome measures include lower limb strength (5 Times Sit-to-Stand Test), balance ability (Timed Up and Go test), gait performance (10-meter walk test, GaitRite), muscle mass index (SMI) using BWA 2.0, muscle thickness (quadriceps via ultrasound), cognitive function (MoCA), depression level (GDS-K).

Outcome assessors are blinded to group allocation. This study has received IRB approval from Sahmyook University Institutional Review Board.

Being tested
Blood flow restriction cuff, Exercise without BFR cuff
Keywords
Blood flow restriction training, Older adults, Muscle mass, Functional Mobility, Cognition
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood flow restriction cuffOther

    Use of blood flow restriction cuff during resistance training. The cuff pressure is set at 50% of the participant's arterial occlusion pressure.

  • Exercise without BFR cuffOther

    Resistance exercise performed without blood flow restriction. Same protocol as BFR group but without cuff application.

Study groups in NCT06962514
Study groupRoleWhat they receive
BFR groupExperimentalExercise with BFR cuff
Receives: Other: Blood flow restriction cuff
Exercise groupExperimentalExercise without BFR cuff
Receives: Other: Exercise without BFR cuff

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quadriceps muscle thickness (via ultrasound)

    Muscle thickness of the rectus femoris and vastus intermedius will be assessed using B-mode ultrasound at rest. Measurements will be taken pre- and post-intervention.

    Measured: From baseline to the end of the 8-week intervention.

  2. Skeletal Muscle Mass Index (SMI)

    SMI will be calculated using appendicular lean mass obtained from bioelectrical impedance analysis (BWA 2.0) and height squared (kg/m²). Handgrip strength will also be assessed as an indicator of muscle function.

    Measured: From baseline to the end of the 8-week intervention.

Secondary outcomes (5)
  1. Lower limb strength (5 Times Sit to Stand Test)

    Lower extremity strength will be assessed using the Five Times Sit to Stand Test, measuring the time required to stand from a chair and sit down five times.

    Measured: From baseline to the end of the 8-week intervention.

  2. Depression level (GDS-K)

    Depressive symptoms will be assessed using the Korean version of the Geriatric Depression Scale (GDS-K), a standardized self-report screening tool for older adults. It consists of 30 items, each answered with "Yes" or "No." The total score ranges from 0 to 30, with higher scores indicating more severe depressive symptoms. Scores are interpreted as follows: 0-13 = normal, 14-18 = mild depression, 19-21 = moderate depression, and 22 or above = severe depression.

    Measured: From baseline to the end of the 8-week intervention.

  3. Cognitive function (MoCA)

    Cognitive function will be evaluated using the Korean version of the Montreal Cognitive Assessment (MoCA-K), a validated screening tool for mild cognitive impairment in older adults. It assesses multiple cognitive domains, including attention, memory, language, visuospatial skills, executive functions, and orientation. The total score ranges from 0 to 30, with higher scores indicating better cognitive performance. A score below 23 is generally considered indicative of cognitive impairment. One point may be added for individuals with 6 or fewer years of formal education.

    Measured: From baseline to the end of the 8-week intervention.

  4. Gait performance (10-meter walk test and Gaitrite)

    Gait speed and spatiotemporal gait parameters will be measured using a 10-meter walk test and GaitRite system at comfortable walking speed.

    Measured: From baseline to the end of the 8-week intervention.

  5. Balance ability (TUG)

    Dynamic balance will be assessed using the Timed Up and Go (TUG) test.

    Measured: From baseline to the end of the 8-week intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2025
  2. Study start12 May 2025
  3. Primary completion10 Jul 2025
  4. Study completion14 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two-group parallel randomized controlled trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06962514
Sponsor's protocol ID
2024-07-005-009
Acronym
BFRT
Status last verified
Jul 2025
First submitted
30 Apr 2025
Last updated
8 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The decision to share individual participant data (IPD) has not been finalized. The data may be considered for sharing after de-identification and upon request, depending on future publication requirements and institutional policy.

Questions about this trial

What is this clinical trial studying?

A study testing Blood flow restriction cuff and Exercise without BFR cuff in people with Blood Flow Restriction Exercise and Resistance Training, run by Sahmyook University at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quadriceps muscle thickness (via ultrasound) (time frame: From baseline to the end of the 8-week intervention.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in